78
Views
1
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Phosphodiesterase 4 inhibition with roflumilast: a new approach to pulmonary disease

VAN SCHALKWYK E, STRYDOM K, WILLIAMS Z et al.: Roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, attenuates allergen-induced asthmatic reactions. J. Allergy Clin. Immunol. (2005) 116:292-298 and RABE KE, BATEMAN ED, O’DONNELL D et al.: Roflumilast – an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial. Lancet (2005) 366:563-571.

Pages 485-488 | Published online: 27 Feb 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (1)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.